Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine ? the REBUILD-2 Study

CGAT Rebuild 2

Phase: III
Clinicaltrials.gov ID: NCT04616326

What is the goal of the study?

This study is being done to see how safe galcanezumab is and how well it will work to help adolescents with chronic migraines.

Who can participate in the study?

This study might be a good fit for you if you: You are 12 to 17 years old at Visit 1 You have a diagnosis of chronic migraine, that is, a headache occurring on 15 or more days per month for at least the last 3 months, which has the features of migraine headache on at least 8 days per month You are up to date on your immunizations

Study Team:

PI (Study Doctor): Heidi Blume
Study Team Member: Mikaela Gatterman, Mikaela.Gatterman@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.